Reasons why Cabergoline is banned in China

The reasons why cabergoline (Cabergoline) has been restricted or prohibited from sale mainly involve its potential for misuse and abuse, as well as the potential for serious side effects. The following are some reasons that may lead to the ban of cabergoline in the country:

1.Abuse and Abuse: Cabergoline is a dopamine receptor agonist commonly used to treat diseases with abnormally elevated dopamine levels, such as pituitary tumors and hyperprolactinemia. However, due to its dopamine receptor activating effects, it can also be abused, particularly in some sports athletes, to enhance performance or reduce muscle fatigue after exercise. This misuse may have adverse health effects.

2.Side effects: The use of cabergoline may cause a series of side effects, including headache, nausea, vomiting, hypotension, arrhythmia and mental status changes. Without physician supervision, patients may not be able to appropriately manage these potential risks.

3.Regulations and Regulations: Concerns in some countries regarding the potential abuse and abuse of the drug, as well as the protection of public health, may result in regulatory and regulatory measures to limit or prohibit the sale of cabergoline.

It is important to note that prohibiting or restricting the sale of cabergoline is intended to ensure public health and safety and to reduce the potential for abuse and inappropriate use. However, regulations and policies may vary between countries and over time, so circumstances may have changed. Patients are advised to consult a medical professional for the latest information and advice before using any medication.

Cabergoline is not currently available in the country, so patients cannot purchase it domestically and need to purchase cabergoline through overseas channels. In foreign countries, cabergoline is the original drug, and the cheaper version is the Turkish original drug, which costs about one to two hundred yuan.